Back to Point72 Asset Management, L.P.

CTMX
6 quarters

Position history for Point72 Asset Management, L.P.'s holdings in CYTOMX THERAPEUTICS INC.

Point72 Asset Management, L.P. holds 7.9M shares of CTMX (CYTOMX THERAPEUTICS INC.), worth $37M as of 2026-Q1. The position was increased (+51.8% shares). CTMX represents 0.0% of Point72 Asset Management, L.P.'s portfolio.

Current Value

$37M

Current Shares

7.9M

Total Value Change

+$34.3M

Total Shares Change

+5.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
7.9M
+51.8%
$37M0.0%$4.81
40
2025-Q4
Increased
5.2M
+27.6%
$22.1M0.0%$4.16
35
2025-Q3
Decreased
4.1M
-49.7%
$13M0.0%$3.23
0
2025-Q2
Increased
8.1M
+205.1%
$18.4M0.0%$2.25
46
2025-Q1
Unchanged
2.7M
0.0%
$1.7M0.0%$0.63
0
2024-Q4
New
2.7M
-
$2.7M0.0%$1.02
36

Other major holders of CTMX: FMR LLC, BANK OF AMERICA CORP /DE/, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used